Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,528 | 7,753 | 19,018 | 1,528 | 1,453 |
| Cost of Goods | 1,869 | 1,514 | 8,223 | 1,068 | 1,155 |
| Gross Profit | 659 | 6,239 | 10,795 | 460 | 298 |
| Operating Expenses | 31,446 | 35,832 | 31,892 | 21,522 | 19,360 |
| Operating Income | -29,918 | -29,079 | -20,874 | -20,994 | -18,907 |
| Other Income | 1,758 | 1,444 | 922 | 462 | 118 |
| Pre-tax Income | -28,160 | -27,635 | -19,952 | -20,532 | -18,789 |
| Net Income Continuous | -28,160 | -27,635 | -19,952 | -20,532 | -18,789 |
| Net Income | $-28,160 | $-27,635 | $-19,952 | $-20,532 | $-18,789 |
| EPS Basic Total Ops | -0.42 | -0.41 | -0.30 | -0.31 | -0.31 |
| EPS Basic Continuous Ops | -0.42 | -0.42 | -0.30 | -0.31 | -0.31 |
| EPS Diluted Total Ops | -0.42 | -0.41 | -0.30 | -0.31 | -0.31 |
| EPS Diluted Continuous Ops | -0.42 | -0.42 | -0.30 | -0.31 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.42 | -0.41 | -0.30 | N/A | N/A |
| EBITDA(a) | $-29,720 | $-28,889 | $-20,681 | $-20,788 | $-18,699 |